Biogen will charge $56,000-a-year for Alzheimer’s drug
Price over double the highest industry analyst estimate triggers renewed criticism
Price over double the highest industry analyst estimate triggers renewed criticism
Dublin group says regulator refusal to allow it discuss off label use breaches US first amendment rights and puts it at a disadvantage to rival unregulated products
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices